NO941318L - Vandig kosmetisk gel med lav pH inneholdende ikke-ioniske polyakrylamid-derivater - Google Patents

Vandig kosmetisk gel med lav pH inneholdende ikke-ioniske polyakrylamid-derivater

Info

Publication number
NO941318L
NO941318L NO941318A NO941318A NO941318L NO 941318 L NO941318 L NO 941318L NO 941318 A NO941318 A NO 941318A NO 941318 A NO941318 A NO 941318A NO 941318 L NO941318 L NO 941318L
Authority
NO
Norway
Prior art keywords
low
containing non
gel containing
aqueous cosmetic
ionic polyacrylamide
Prior art date
Application number
NO941318A
Other languages
English (en)
Norwegian (no)
Other versions
NO941318D0 (no
Inventor
George Endel Deckner
Brian Scott Lombardo
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of NO941318D0 publication Critical patent/NO941318D0/no
Publication of NO941318L publication Critical patent/NO941318L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Anesthesiology (AREA)
  • Birds (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
NO941318A 1991-10-16 1994-04-13 Vandig kosmetisk gel med lav pH inneholdende ikke-ioniske polyakrylamid-derivater NO941318L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77842391A 1991-10-16 1991-10-16
PCT/US1992/008743 WO1993007856A1 (fr) 1991-10-16 1992-10-13 GEL COSMETIQUE AQUEUX A pH FAIBLE CONTENANT DES DERIVES DE POLYACRYLAMIDE NON IONIQUE

Publications (2)

Publication Number Publication Date
NO941318D0 NO941318D0 (no) 1994-04-13
NO941318L true NO941318L (no) 1994-06-15

Family

ID=25113303

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941318A NO941318L (no) 1991-10-16 1994-04-13 Vandig kosmetisk gel med lav pH inneholdende ikke-ioniske polyakrylamid-derivater

Country Status (25)

Country Link
US (1) US5707635A (fr)
EP (1) EP0608353B1 (fr)
JP (1) JP3555762B2 (fr)
KR (1) KR100244554B1 (fr)
CN (1) CN1050283C (fr)
AT (1) ATE133560T1 (fr)
AU (1) AU675210B2 (fr)
BR (1) BR9206630A (fr)
CA (1) CA2119636C (fr)
CZ (1) CZ90494A3 (fr)
DE (1) DE69208098T2 (fr)
DK (1) DK0608353T3 (fr)
ES (1) ES2083197T3 (fr)
FI (1) FI941769A0 (fr)
GR (1) GR3018853T3 (fr)
HK (1) HK1007504A1 (fr)
HU (1) HUT66957A (fr)
MA (1) MA22677A1 (fr)
MX (1) MX9205905A (fr)
NO (1) NO941318L (fr)
NZ (1) NZ244744A (fr)
PT (1) PT100962B (fr)
SK (1) SK43994A3 (fr)
TR (1) TR26721A (fr)
WO (1) WO1993007856A1 (fr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT74560A (en) * 1991-10-16 1997-01-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
EG20380A (en) 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
JPH07506367A (ja) * 1992-05-05 1995-07-13 ザ、プロクター、エンド、ギャンブル、カンパニー アクネ治療組成物
CA2141192C (fr) * 1992-07-28 1999-02-02 Roberta C. Bloom Composition pharmaceutique pour utilisation topique contenant un polymere cationique reticule et un ether alkoxyle
US5989536A (en) * 1993-07-03 1999-11-23 The Procter & Gamble Company Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin
US6001379A (en) * 1993-09-15 1999-12-14 L'oreal Stable acidic oil-in- water type emulsions and compositions containing them
FR2709982B1 (fr) * 1993-09-15 1995-12-08 Oreal Emulsions acides stables de type huile-dans-eau et compositions les contenant.
ZA947912B (en) * 1993-10-12 1995-05-24 Broadbent J W Nominees Pty Ltd Treatment of medical disorders associated with free radical formation
FR2718640B1 (fr) * 1994-04-18 1996-05-15 Oreal Composition cosmétique et/ou dermatologique notamment pour dépigmenter la peau, ses utilisations.
US5422112A (en) * 1994-06-09 1995-06-06 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Thickened cosmetic compositions
DE19538555A1 (de) * 1995-10-17 1997-04-24 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Wirkstoffkombinationen
NL1003992C2 (nl) * 1996-09-10 1998-03-11 Stein Gerrit Cornelis Johan Therapeutische gel met ongeneutraliseerde alfa-hydroxyzuren als werkzame componenten.
FR2759286B1 (fr) * 1997-02-10 2004-04-02 Oreal Utilisation de polymeres presentant une temperature critique du type lcst ou du type ucst dans et pour la fabrication de formulations cosmetiques ou dermatologiques compositions les contenant
US20030150575A1 (en) * 1998-06-04 2003-08-14 Snf Sa Paper and paperboard production process and corresponding novel retention and drainage aids, and papers and paperboards thus obtained
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
US6200964B1 (en) 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
JP2001031549A (ja) * 1999-07-14 2001-02-06 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料
US6342206B1 (en) * 1999-12-27 2002-01-29 Sridhar Gopalkrishnan Aqueous gels comprising ethoxylated polyhydric alcohols
US6335001B1 (en) * 1999-12-27 2002-01-01 Basf Corporation Carrier blends for dentifrices comprising ethoxlated polyhydric alcohols
US6632845B1 (en) * 2000-06-26 2003-10-14 Diane M. Gassiraro Method for improving muscle control and muscle tone and improving sensory integration
FR2810883B1 (fr) 2000-06-28 2006-07-28 Seppic Sa Nouveaux latex inverses autoinversibles sur des esters d'acides gras, compositions cosmetiques, dermocosmetiques, dermopharmaceutiques ou pharmaceutiques en comportant
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
ATE316786T1 (de) * 2000-11-22 2006-02-15 Rxkinetix Inc Behandlung von mukositis
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
FR2829937B1 (fr) * 2001-09-24 2004-11-05 Fabre Pierre Dermo Cosmetique Composition dermocosmetologique a visee anti-inflammatoire, en particulier pour le traitement de l'acne et de la dermite seborrheique
US7074832B2 (en) 2001-09-24 2006-07-11 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
FR2829938B1 (fr) * 2001-09-24 2004-10-29 Fabre Pierre Dermo Cosmetique Composition dermocosmetologique a visee anti-inflammatoire, en particulier pour le traitement de l'acne et de la dermite seborrheique
US20030064084A1 (en) * 2001-09-24 2003-04-03 Bradley Pharmaceuticals, Inc. Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
US20030138466A1 (en) * 2001-11-28 2003-07-24 Bradley Pharmaceuticals, Inc. Antioxidant dermatological composition
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US6986896B2 (en) * 2002-03-20 2006-01-17 Bradley Pharmaceuticals, Inc. Method of treating fungal conditions of the skin
US6743417B2 (en) 2002-04-22 2004-06-01 Bradley Pharmaceuticals, Inc. Method of treating onychomycosis with urea and an antioxidant
US20030206893A1 (en) * 2002-05-06 2003-11-06 Sohail Malik Cell proliferating agents
US20040043946A1 (en) * 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US20040156870A1 (en) * 2003-02-11 2004-08-12 Bradley Pharmaceuticals, Inc. Use of urea as a method for improving the effectiveness of topical anti-inflammatory drugs
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
FR2856691B1 (fr) 2003-06-26 2005-08-26 Seppic Sa Nouveau polymere en poudre, procede pour sa preparation et utilisation comme epaississant
FR2861397B1 (fr) 2003-10-22 2006-01-20 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse concentre, procede pour sa preparation et utilisation dans l'industrie
FR2867070B1 (fr) * 2004-03-04 2009-07-10 Oreal Gel autobronzant transparent contenant un polymere d'acide acrylamido 2-methyl propane sulfonique hydrosoluble ou hydrodispersible
US9572754B2 (en) 2004-03-04 2017-02-21 L'oreal Transparent self-tanning gels containing a water-soluble/dispersible acrylamido-2-methylpropanesulfonic acid polymer
US8158138B1 (en) 2004-05-20 2012-04-17 Fougera Pharmaceuticals, Inc. Urea compositions and their methods of manufacture
FR2879607B1 (fr) 2004-12-16 2007-03-30 Seppic Sa Nouveaux latex inverse concentre, procede pour sa preparation, et utilisation dans l'industrie
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
DK1965787T3 (da) * 2005-11-30 2013-06-03 Endo Pharmaceuticals Inc Behandling af xerostomi med en svovlindeholdende antioxidant
US9107844B2 (en) * 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Res Australia Pty Ltd gel de suspensão espumante
CN100446773C (zh) * 2006-04-29 2008-12-31 王菊荣 复方痤疮微乳膏及制备方法
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
CN100463930C (zh) * 2006-12-21 2009-02-25 天津大学 可再分散pH敏感型阳离子聚合物水凝胶亚微米粒及制备方法
FR2950060B1 (fr) 2009-09-11 2011-10-28 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau polymere en poudre, procede pour sa preparation et utilisation comme epaississant
FR2959746B1 (fr) 2010-05-06 2012-06-15 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse auto-inversible, son utilisation comme agent epaississant dans une composition cosmetique
FR2969493B1 (fr) * 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo
FR2969491B1 (fr) * 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
JP5840437B2 (ja) * 2011-09-30 2016-01-06 日本メナード化粧品株式会社 抗炎症剤
FR2986004B1 (fr) 2012-01-25 2014-03-14 Seppic Sa Nouveau polymere epaississant reduisant le caractere collant des formules cosmetiques a base de glycerine
FR2987361B1 (fr) 2012-02-29 2014-07-18 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau polymere d'acrylate de silicone et de methacrylate de trifluoro-ethyle, preparation et utilisation en cosmetique
FR2987839B1 (fr) 2012-03-08 2014-05-09 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau polymere d'acrylate de silicone et d'acide acrylique epaississant et reduisant le caractere collant des formules cosmetiques a base de glycerine
FR2992323B1 (fr) 2012-06-25 2015-07-03 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse auto-inversible exempt de tensioactif, son utilisation comme agent epaississant dans une composition cosmetique
CN104780902A (zh) * 2012-10-29 2015-07-15 日本乐敦制药株式会社 外用组合物
US9174871B2 (en) 2012-11-02 2015-11-03 Empire Technology Development Llc Cement slurries having pyranose polymers
CN102885764A (zh) * 2012-11-02 2013-01-23 江苏吉贝尔药业有限公司 一种新的乙酰半胱氨酸凝胶的制备方法
US9238774B2 (en) 2012-11-02 2016-01-19 Empire Technology Development Llc Soil fixation, dust suppression and water retention
WO2014088555A1 (fr) 2012-12-04 2014-06-12 Empire Technology Development Llc Adhésifs en acrylamide à hautes performances
EP3432859B1 (fr) * 2016-03-23 2021-07-14 Mary Kay, Inc. Compositions cosmétiques et leurs utilisations
CN110785161B (zh) 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
US20210102059A1 (en) * 2018-03-30 2021-04-08 Sekisui Kasei Co., Ltd. Hydrogel
CN108467464A (zh) * 2018-04-02 2018-08-31 常熟理工学院 含壬二酸可见光固化水凝胶及其制备方法
CA3102288A1 (fr) 2018-07-03 2020-01-09 The Procter & Gamble Company Methode de traitement d'une affection cutanee
CN108553411B (zh) * 2018-07-25 2020-05-12 成都卓阳生物科技有限公司 壬二酸凝胶剂及其制备方法和应用
US11154472B2 (en) * 2019-04-29 2021-10-26 L'oreal Compositions comprising solvent, a monoalcohol, glycerin, and thickener
WO2021247496A1 (fr) 2020-06-01 2021-12-09 The Procter & Gamble Company Méthode d'amélioration de la pénétration d'un composé de vitamine b3 dans la peau
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920810A (en) 1974-04-23 1975-11-18 Burton Parsons And Company Inc Polyacrylamide containing ophthalmic solutions
US4039501A (en) * 1975-05-30 1977-08-02 National Patent Development Corporation Plasticized hydrophilic polymers
US4318907A (en) * 1978-04-04 1982-03-09 Westwood Pharmaceuticals, Inc. Method for treating acne vulgaris and compositions useful for that purpose
US4355028A (en) * 1978-04-04 1982-10-19 Westwood Pharmaceuticals, Inc. Composition for treating acne vulgaris
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
JPS596287B2 (ja) * 1980-11-28 1984-02-10 日東電工株式会社 医薬製剤
AU8409582A (en) * 1981-06-15 1982-12-23 Alcon Laboratories, Inc. Urea and carboxyvinyl polymers gel compositions
US4478853A (en) * 1982-05-17 1984-10-23 S. C. Johnson & Son, Inc. Skin conditioning composition
US4540568A (en) * 1982-10-14 1985-09-10 Trager Seymour F Injectionable viscoelastic ophthalmic gel
US4863725A (en) 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
GB8401206D0 (en) 1984-01-17 1984-02-22 Allied Colloids Ltd Polymers and aqueous solutions
GB8414950D0 (en) 1984-06-12 1984-07-18 Allied Colloids Ltd Cationic polyelectrolytes
GB8416453D0 (en) * 1984-06-28 1984-08-01 Allied Colloids Ltd Aqueous polymer dispersions
US5017367A (en) * 1984-10-01 1991-05-21 Stojkoski Radmila G Skin treatment preparation
US4806345C1 (en) * 1985-11-21 2001-02-06 Johnson & Son Inc C Cross-linked cationic polymers for use in personal care products
GB8531118D0 (en) * 1985-12-18 1986-01-29 Allied Colloids Ltd Copolymers
US4827019A (en) * 1985-12-24 1989-05-02 Eastman Kodak Company Sterically hindered aromatic carboxylic esters
US4731242A (en) * 1986-03-21 1988-03-15 Victor Palinczar Waterproof sunscreen compositions
US4704436A (en) * 1986-05-02 1987-11-03 Barabas Eugene S Water soluble complex of a poly(vinylpyrrolidone) copolymer and α-methyl-(2-methylpropyl)benzene acetic acid
US4837019A (en) 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
GB8622797D0 (en) * 1986-09-22 1986-10-29 Allied Colloids Ltd Polymeric particles
DE3788696T2 (de) * 1986-10-01 1994-04-28 Allied Colloids Ltd Wasserlösliche Polymerzusammensetzung.
CA1305069C (fr) 1987-03-11 1992-07-14 John Cornell Pansement en feuille ou en gelee
US4929577A (en) * 1987-03-11 1990-05-29 Medi-Tech International Corporation Transparent wound dressings in sheet form
US4885161A (en) * 1987-03-11 1989-12-05 Medi-Tech International Corporation Wound dressings in gelled paste form
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
JPH07116035B2 (ja) * 1987-12-08 1995-12-13 塩野義製薬株式会社 被膜形成性抗真菌剤組成物
US4963348A (en) 1987-12-11 1990-10-16 The Procter & Gamble Company Styling agents and compositions containing the same
JPH0749050B2 (ja) * 1988-01-18 1995-05-31 久光製薬株式会社 含水ゲル組成物
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
GB8909095D0 (en) * 1989-04-21 1989-06-07 Allied Colloids Ltd Thickened aqueous compositions
US5009969A (en) * 1989-05-26 1991-04-23 Hi-Tek Polymers, Inc. Dual action sunscreen composition
GB2236760A (en) * 1989-10-11 1991-04-17 Inverness Corp Shaving gel
US5043359A (en) * 1990-03-05 1991-08-27 Dow Corning Corporation Skin conditioning compositions containing glyceroxyfunctional silanes and siloxanes
US5221530A (en) * 1991-06-24 1993-06-22 Helene Curtis, Inc. Mild conditioning shampoo with a high foam level containing an anionic surfactant-cationic acrylate/acrylamide copolymer conditioning agent
EG20380A (en) * 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
HUT74560A (en) * 1991-10-16 1997-01-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
US5232688A (en) * 1992-06-17 1993-08-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Self-tanner cosmetic compositions
US5425938A (en) * 1994-01-28 1995-06-20 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Polyamino salts of alpha-hydroxyacids, alpha-ketoacids and related compounds

Also Published As

Publication number Publication date
PT100962B (pt) 1999-07-30
WO1993007856A1 (fr) 1993-04-29
HU9401105D0 (en) 1994-07-28
AU675210B2 (en) 1997-01-30
TR26721A (tr) 1995-05-15
CA2119636C (fr) 1998-06-23
DE69208098D1 (de) 1996-03-14
PT100962A (pt) 1993-11-30
HUT66957A (en) 1995-01-30
DK0608353T3 (da) 1996-07-01
BR9206630A (pt) 1995-04-25
CN1050283C (zh) 2000-03-15
KR100244554B1 (ko) 2000-04-01
ES2083197T3 (es) 1996-04-01
FI941769A (fi) 1994-04-15
JP3555762B2 (ja) 2004-08-18
DE69208098T2 (de) 1996-08-08
FI941769A0 (fi) 1994-04-15
MA22677A1 (fr) 1993-07-01
US5707635A (en) 1998-01-13
EP0608353A1 (fr) 1994-08-03
JPH07500593A (ja) 1995-01-19
EP0608353B1 (fr) 1996-01-31
MX9205905A (es) 1993-06-01
HK1007504A1 (en) 1999-04-16
NZ244744A (en) 1995-07-26
NO941318D0 (no) 1994-04-13
SK43994A3 (en) 1995-01-12
GR3018853T3 (en) 1996-05-31
ATE133560T1 (de) 1996-02-15
AU2800092A (en) 1993-05-21
CA2119636A1 (fr) 1993-04-29
CZ90494A3 (en) 1994-07-13
CN1072843A (zh) 1993-06-09

Similar Documents

Publication Publication Date Title
NO941318L (no) Vandig kosmetisk gel med lav pH inneholdende ikke-ioniske polyakrylamid-derivater
ES2123922T3 (es) Utilizacion de un antagonista de substancia p en una composicion cosmetica y composicion obtenida.
BR9403783A (pt) Uso de uma composição cosmética
ATE65180T1 (de) Haarpflegemittel.
SE8104858L (sv) Dental komposition
DK295190A (da) Kosmetik- og hudbehandlingssammensaetninger
FI932453A0 (fi) Geltypkompositioner med foerbaettrad fettkontroll
KR970009581B1 (en) Composition for topical use containing depolymerized deoxyribonucleic acids in the skin and body cosmetic treathent
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
AU1439199A (en) Use of a diphenyldimethicone dissolved in a non-volatile silicone such as phenyltrimethicone for making a cosmetic or pharmaceutical, in particular dermatological, composition comprising a fatty phase
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
RU94019979A (ru) Косметическая композиция с низким значением рн, содержащая неионные полиакриламидные производные
MX9709941A (es) Nueva composicion farmaceutica con efecto anestesico.